The diarylquinoline F 1 F O -ATP synthase inhibitor bedaquiline (BDQ) displays protonophore activity. Thus, uncoupling electron transport from ATP synthesis appears to be a second mechanism of action of this antimycobacterial drug. Here, we show that the new BDQ analogue TBAJ-876 did not retain the parental drug's protonophore activity. Comparative time-kill analyses revealed that both compounds exert the same bactericidal activity. These results suggest that the uncoupler activity is not required for the bactericidal activity of diarylquinolines.
vesicles. The addition of 0.5 mM succinate resulted in quenching of ACMA fluorescence, thus indicating pH change due to the establishment of the pH gradient across the vesicles' membrane ( Fig. 2) . One micromolar of the bona fide protonophore SF6847 (Sigma-Aldrich, USA) was used as a positive control to collapse the pH gradient at the end of each experiment, as detected by the loss of fluorescence quenching (Fig. 2 ). BDQ (MedChemExpress, USA) caused a dose-dependent reduction of ACMA fluorescence quenching ( Fig. 2A ). Fifteen micromolar of the drug caused a complete reversal of quenching, thus indicating elimination of the pH gradient ( Fig. 2A ). These two observations are consistent with previous reports on BDQ's effect on the transmembrane pH gradient (8, 9) . Hence, these results confirm that BDQ displays protonophore activity and thus uncouples electron transport from ATP synthesis. In contrast, 15 M TBAJ-876 reduced quenching by only 20% and thus had a much weaker effect on the transmembrane pH gradient than BDQ (Fig. 2B ). The effect of BDQ and TBAJ-876 on the transmembrane pH gradient was also assessed using NADH as an electron donor to energize the vesicles. The uncoupling effect of 15 M BDQ was drastically reduced in NADH-energized membrane vesicles (Fig. 2C ). This is consistent with a previous report by Hards and Cook who showed that the uncoupling effect of BDQ is influenced by the electron donor used for respiration (19) . Consistent with the results from the succinateenergized vesicles, 15 M TBAJ-876 had a weaker effect than BDQ on the transmembrane pH gradient in NADH-energized vesicles (Fig. 2C) . Collectively, the results suggest that TBAJ-876 did not retain BDQ's pronounced protonophore activity.
The weaker protonophore activity of TBAJ-876 may be a result of its less lipophilic character, limiting its ability to diffuse through lipid-rich membranes and thus preventing it from acting as an efficient proton translocator. In a previous study, it was shown that the weakly basic BDQ readily crosses lipid bilayers to accumulate within the cell interior. This was detected by rapid alkalization of the interior of Escherichia coli liposomes by 1 M BDQ in the absence of a pH gradient between the liposome interior and exterior (8) . If TBAJ-876 (also a weak base) is indeed less effective in diffusing through lipid bilayers than BDQ, the compound should be less effective in causing 
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Antimicrobial Agents and Chemotherapy intracellular alkalization. To test this, we treated Mycobacterium bovis bacillus Calmette-Guérin (BCG; ATCC 35734) cultures with 0.1, 1, and 10 M TBAJ-876 or BDQ and measured the effects on intracellular pH, in the absence of a pH gradient between the cell interior and exterior, using the pH-sensitive fluorophore 5-chloromethylfluorescein diacetate (CMFDA; Invitrogen, USA) as described previously (20) . Consistent with the previous E. coli liposome study (8) , treatment with 1 M BDQ caused a rapid intracellular pH increase of 0.35 units within 20 min (Fig. 3) . In contrast, 1 M TBAJ-876 had a weaker effect (0.17 pH unit increase), and treatment with 10 M was required to cause a 0.35 unit increase of intracellular pH (Fig. 3) . These data support the notion that TBAJ-876 is indeed less effective than BDQ in crossing membranes and are consistent with the compound's weaker protonophore activity observed in the inverted vesicle experiments. The uncoupler activity is proposed to contribute to BDQ's bactericidal activity (9) . Hence, the weaker protonophore activity in TBAJ-876 should reduce the compound's bactericidal activity. To determine the impact of the weakened protonophore activity on TBAJ-876's bactericidal activity, we carried out comparative time-kill experiments with M. tuberculosis H37Rv (ATCC 27294) as described previously (21) . Cultures were treated over 21 days with 3-, 30-, or 300-fold the MIC 90 of BDQ or TBAJ-876. Subsequently, bacterial viability was determined by enumeration of CFU. Surprisingly, the kill curves generated by BDQ and TBAJ-876 were indistinguishable, showing that both molecules exert the same bactericidal activity (Fig. 4) . This result suggests that the reduced uncoupler activity of TBAJ-876 does not affect the compound's bactericidal activity.
In conclusion, we show that the 3,5-dialkoxypyridine BDQ analogue TBAJ-876 does not retain the parental drug's strong uncoupler activity. This is likely due to TBAJ-876's lower lipophilicity, limiting the compound's ability to diffuse through lipid bilayers and consequently weakening the compound's protonophore activity. Unexpectedly, loss of uncoupler activity did not affect the bactericidal activity of TBAJ-876. Our results suggest that uncoupler activity is not critical for members of the diarylquinoline class to exert their antimycobacterial activity. 
